Table 1 Survey questions.
Q1. What is your preferred method for establishing a pneumoperitoneum in patients with a normal Body Mass Index (BMI)? |
Q2. What is your preferred method for establishing a pneumoperitoneum in patients with a high BMI? |
Q3. Roughly, after how many procedures were you comfortable enough in using the Veress needle? |
Q4. Roughly, after how many procedures were you comfortable enough in using the Hasson method? |
Q5. When did you pick your preferred method? During training/Following personal experience during surgery/Other |
Q6. Where did you learn how to perform a pneumoperitoneum? In the clinical skills lab/on the job training/Other |
Q7. What is your preferred (primary) entry location in normal BMI patients? Lee-Huang point/Palmer’s point/Umbilical point |
Q8. What is your preferred (primary) entry location in high BMI patients? Lee-Huang point/Palmer’s point/Umbilical point |
Q9. How do you hold the Veress needle (see images below)? At the shaft/At the base |
Q10. Do you have a preferred type of Veress needle? Yes/No |
Q11. If yes, which one and why do you prefer it? |
Q12. Do you agree with the following statement: Decreasing overshooting increases the overall safety of the Closed technique no 1/2/3/4/5 yes |
Q13. Do you agree with the following statement: Decreasing the learning curve of the Veress Needle use increases the overall safety of the Closed technique no 1/2/3/4/5 yes |
Q14. Do you agree with the following statement: Increase in Body Mass Index is directly related to an increased risk of complications during first entry no 1/2/3/4/5 yes |
Q15. Do you agree with the following statements: Improving the sustainability of hospital processes and operations is important to me no 1/2/3/4/5 yes |
Q16. In your opinion, how far beyond the peritoneum (Ideal Insertion Depth) does the Veress needle tip need to be for safe insufflation (in mm)? |
Q17. In adopting new surgical technology/products do you consider yourself an: Innovator/Early adopter/Early majority/Late majority/Laggard |
Q18. What are your main concerns about using NEW medtech devices during surgery? |
Q19. If the above claims are true would you consider using the new VeressPLUS in patients with a normal BMI? no 1/2/3/4/5 yes |
Q20. Please explain your answer |
Q21. If the above claims are true, would you consider using the new VeressPLUS in patients with a high BMI? |
Q22. Please explain your answer |
Q23. Age |
Q24. Gender |
Q25. Nationality |
Q26. Years of experience (as a surgeon) |
Q27. Estimated number of Veress needle use |
Q28. Place of work Training hospital/Non-training hospital/Private clinic/Academia/Other |
Q29. Surgical specialty |
Q30. Dominant hand |
Q31. Would you be interested in joining the VeressPLUS R&D project as an innovator/early adopter? |
If yes, please share your contact details below |
